Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Copyright Confusion Has 'Chilling' Effects in Online Creative Publishing

  • Human mind: Making sense through order

  • Amputee makes history controlling two modular prosthetic limbs

  • Scientists map out how childhood brain tumors relapse

  • Scheduling sleep: Three nighttime habits to improve rest

  • Ability to balance on one leg may reflect brain health, stroke risk

  • Being humble: Research shows E.B. White was right in Charlotte's Web

  • Outreach program gets cessation help to smokers of low socioeconomic status

  • Yoga has potential to reduce risk factors of cardiovascular disease

  • How does prostate cancer form? Parkinson's Link?

  •